Vitamin C zinc lozenges market seen reaching $3.49 billion by 2030

The vitamin C zinc lozenges market is projected to grow from $2.47 billion in 2026 to $3.49 billion by 2030, fueled by preventive healthcare, flu demand and e-commerce expansion. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Vitamin C zinc lozenges are gaining share as consumers look for immune-support products that are easy to take and widely available. - The category is benefiting from persistent demand for preventive supplements, especially during cold and flu seasons. - The market’s expected rise to $3.49 billion by 2030 signals continued growth in functional nutrition and self-care spending.

What happened: - The Business Research Company released its Vitamin C Zinc Lozenges Global Market Report 2026. - The report says the market will grow from $2.27 billion in 2025 to $2.47 billion in 2026. - The report projects the market will reach $3.49 billion by 2030. - The report links that outlook to an 8.8% CAGR from 2025 to 2026 and a 9.0% CAGR through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Vitamin C zinc lozenges deliver vitamin C and zinc in a slow-releasing oral format. - The lozenges are designed to support immune function and provide localized throat relief. - The format is positioned for consumers seeking simple daily supplementation and cold-season symptom support. - Market growth has been supported by rising awareness of immune health, more seasonal respiratory infections, broader retail distribution of supplements and routine vitamin use. - The report says preventive immune supplements, personalized nutrition, functional health products, online pharmacies and direct-to-consumer sales will help drive future growth. - Sugar-free, natural and plant-based formulas are also shaping product demand. - The report says combination products pairing vitamin C and zinc are becoming more popular. - The analysis covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America and Asia-Pacific. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated charts. - The release includes a sample report link: Download a free sample of the market report. - The release also includes the full report link: View the full market report.

Between the lines: - Preventive healthcare is becoming a bigger purchasing driver as consumers try to avoid illness before it starts. - Flu activity appears to be reinforcing demand for products marketed around immune support and throat soothing. - E-commerce is making supplement shopping easier and more frequent, which should help smaller impulse-driven categories like lozenges. - The shift toward sugar-free and natural formulas suggests consumers want wellness products that fit broader dietary preferences, not just symptom relief.

What's next: - The market’s next phase of growth will likely come from online sales, subscription purchasing and broader adoption of personalized nutrition products. - Product development is likely to stay focused on combination formulas, plant-based ingredients and functional lozenges for throat comfort. - Asia-Pacific’s faster growth could reshape regional competition as supplement brands expand distribution beyond North America.

The bottom line: - Vitamin C zinc lozenges are moving from a seasonal add-on to a broader immune-health category with steady global growth ahead.